Scientists create new cell lines from ocular melanoma patients

Mar 11, 2011

Researchers at UCLA's Jules Stein Eye Institute have created new tumor cell lines from fine-needle biopsies of ocular melanoma patients who had undergone treatment but died when their cancer spread aggressively.

These new cell lines will afford scientists valuable insights into how the eye cancer causes rapid metastasis. The findings could lead to new methods for testing drugs for treatment.   

Until now, scientists have had a limited number of models for studying ocular . The cancer does not naturally occur in animals, and commercially available may differ from the original

"Each cell line retained the molecular features found in its original tumor," said principal investigator Dr. Tara McCannel. "That's important, because the more closely a model resembles the actual tumor, the more likely that discoveries made using the model are to be valid."

Ocular melanoma, which forms in the pigmented layers under the retina, is the most common in adults, with approximately 2,000 new cases (seven in 1 million people) diagnosed each year. The cause remains unknown.

Patients whose tumors contain a genetic marker linked to rapid metastasis have at least a 50 percent chance of death within five years, due to swift spreading of the tumor to the liver and other organs. Particularly aggressive cases can result in blindness and death within a year.

Explore further: Survival differences seen for advanced-stage laryngeal cancer

More information: The research appears in the Feb. 25 online edition of the journal Molecular Vision.

add to favorites email to friend print save as pdf

Related Stories

Melanoma uses body's immune system to spread to lungs

Sep 24, 2010

(PhysOrg.com) -- The way melanoma cells use the immune system to spread and develop into lung tumors may lead to a therapy to decrease development of these tumors, according to Penn State researchers.

Recommended for you

Survival differences seen for advanced-stage laryngeal cancer

Nov 27, 2014

The five-year survival rate for advanced-stage laryngeal cancer was higher than national levels in a small study at a single academic center performing a high rate of surgical therapy, including a total laryngectomy (removal ...

Gene test aids cancer profile

Nov 27, 2014

The first round of chemotherapy did little to suppress Ron Bose's leukemia. The second round, with 10 times the dose, knocked the proliferating blast cells down, but only by half.

Hospital volume not linked to costs of cancer surgery

Nov 26, 2014

(HealthDay)—Hospital surgical volume does not appear to correlate with Medicare payments for cancer surgery, according to research published online Nov. 24 in the Journal of Clinical Oncology.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.